Tang-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
202
Total Value
1807581363
Accession Number
0001214659-25-007882
Form Type
13F-HR
Manager Name
Tang-Capital-Management
Data Enrichment
98% identified
198 identified4 unidentified

Holdings

202 positions
Manager:
Search and click to pin securities to the top
Page 4 of 11
Nuvation Bio Inc.
Shares:3.9M
Value:$6.9M
ESSA Pharma Inc.
Shares:4.3M
Value:$6.8M
Edgewise Therapeutics, Inc.
Shares:300.0K
Value:$6.6M
Viking Therapeutics, Inc.
Shares:270.0K
Value:$6.5M
Design Therapeutics, Inc.
Shares:1.7M
Value:$6.5M
REGENERON PHARMACEUTICALS, INC.
Shares:10.0K
Value:$6.3M
Adicet Bio, Inc.
Shares:8.2M
Value:$6.2M
BioAge Labs, Inc.
Shares:1.6M
Value:$6.0M
BIOCRYST PHARMACEUTICALS INC
Shares:800.0K
Value:$6.0M
IOVANCE BIOTHERAPEUTICS, INC.
Shares:1.8M
Value:$6.0M
AbCellera Biologics Inc.
Shares:2.6M
Value:$5.8M
ROCKET PHARMACEUTICALS, INC.
Shares:850.0K
Value:$5.7M
HERON THERAPEUTICS, INC. /DE/
Shares:2.2M
Value:$4.9M
Lantheus Holdings, Inc.
Shares:50.0K
Value:$4.9M
Dianthus Therapeutics, Inc. /DE/
Shares:264.7K
Value:$4.8M
BIOGEN INC.
Shares:35.0K
Value:$4.8M
IONIS PHARMACEUTICALS INC
Shares:150.0K
Value:$4.5M
CytomX Therapeutics, Inc.
Shares:6.7M
Value:$4.3M
Merus N.V.
Shares:100.0K
Value:$4.2M
Coherus BioSciences, Inc.
Shares:5.1M
Value:$4.1M